195 related articles for article (PubMed ID: 31215811)
1. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
2. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
3. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
4. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
[TBL] [Abstract][Full Text] [Related]
5. Identifying the emerging role of adipokine as a diagnostic and prognostic biomarker of renal cell carcinoma.
Choi SH; Chun SY; Kim TH; Kwon TG
Urol Oncol; 2016 Jun; 34(6):259.e15-9. PubMed ID: 26992934
[TBL] [Abstract][Full Text] [Related]
6. Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma.
Kushlinskii NE; Gershtein ES; Morozov AA; Goryacheva IO; Filipenko ML; Alferov AA; Bezhanova SD; Bazaev VV; Kazantseva IA
Bull Exp Biol Med; 2019 Jan; 166(3):353-357. PubMed ID: 30627905
[TBL] [Abstract][Full Text] [Related]
7. Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: A meta-analysis.
Fang J; Xu X; Mao Q; Ying Y; Zhang X; Xie L
Int J Biol Markers; 2020 Mar; 35(1):57-64. PubMed ID: 31973613
[TBL] [Abstract][Full Text] [Related]
8. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
10. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
11. Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells.
Li G; Passebosc-Faure K; Gentil-Perret A; Lambert C; Genin C; Tostain J
Anticancer Res; 2005; 25(1A):377-81. PubMed ID: 15816561
[TBL] [Abstract][Full Text] [Related]
12. Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysis.
Zhang L; Jiang H; Xu G; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y
Mol Med Rep; 2015 Jun; 11(6):4093-100. PubMed ID: 25673070
[TBL] [Abstract][Full Text] [Related]
13. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
[TBL] [Abstract][Full Text] [Related]
14. Low adiponectin levels are associated with renal cell carcinoma: a case-control study.
Spyridopoulos TN; Petridou ET; Skalkidou A; Dessypris N; Chrousos GP; Mantzoros CS;
Int J Cancer; 2007 Apr; 120(7):1573-8. PubMed ID: 17205522
[TBL] [Abstract][Full Text] [Related]
15. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Pinthus JH; Kleinmann N; Tisdale B; Chatterjee S; Lu JP; Gillis A; Hamlet T; Singh G; Farrokhyar F; Kapoor A
Eur Urol; 2008 Oct; 54(4):866-73. PubMed ID: 18343565
[TBL] [Abstract][Full Text] [Related]
16. Association between leptin level and renal cell carcinoma susceptibility and progression: A meta-analysis.
Zhu H; Li W; Mao S; Wang L
J Cancer Res Ther; 2018; 14(4):873-880. PubMed ID: 29970669
[TBL] [Abstract][Full Text] [Related]
17. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.
Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ
Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597
[TBL] [Abstract][Full Text] [Related]
18. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
19. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype.
Papadopoulos EI; Petraki C; Gregorakis A; Fragoulis EG; Scorilas A
Biol Chem; 2016 Jun; 397(6):529-39. PubMed ID: 26866880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
